Publikasi Scopus 2024 per tanggal 30 November 2024 (994 artikel)

Shakinah S.; Nelwan E.J.; Lubis A.M.; Sinto R.; Lie K.C.
Shakinah, Sharifah (57428569400); Nelwan, Erni Juwita (14527452900); Lubis, Anna Mira (56702707800); Sinto, Robert (36099377100); Lie, Khie Chen (59024808400)
57428569400; 14527452900; 56702707800; 36099377100; 59024808400
Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
2024
Acta Medica Indonesiana
56
3
341
348
7
0
Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakart, Indonesia
Shakinah S., Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Nelwan E.J., Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Lubis A.M., Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakart, Indonesia; Sinto R., Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Lie K.C., Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Background: Febrile neutropenia (FN) is an oncologic emergency which commonly occurrs in patients who undergo chemotherapy, with a mortality rate of 12.5%. Risk stratification in FN plays an important role in increasing the accuracy of therapy. This study aims to compare the performance between CISNE score and MASCC score in predicting complications on post-chemotherapy FN in solid and hematologic malignancy. Methods: This is a retrospective cohort study on FN patients undergoing inpatient treatment at Cipto Mangunkusumo Hospital between July 2015 and December 2019. Basic demographic and clinical data were collected from medical records. Subjects were grouped based on the CISNE and MASCC score, and complications during hospitalization were recorded. Predictive performance of each score was analyzed and compared using area of under curve. Results: CISNE score showed a better performance both in solid malignancy with AUC of CISNE score (0.80 CI 95% 0.73-0.88, p = 0.00) compared to AUC of MASCC score (0.68; 95% CI 0.59 – 0,78, p = 0.00) and in hematologic malignancy with AUC of CISNE score (0.85; 95% CI 0.77-0.93, p = 0.00) and AUC MASCC score (0.65; 95% CI 0.54-0.76, p = 0.007). Conclusion: CISNE score showed a better performance compared to MASCC score in predicting in-hospital complication in both solid and hematologic malignancy with cut-off point of 2. © 2024, Indonesian Society of Internal Medicine. All rights reserved.
CISNE; infectious disease; MASCC score; oncology
Adult; Aged; Antineoplastic Agents; Area Under Curve; Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia; Female; Hematologic Neoplasms; Hospitalization; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Assessment; ROC Curve; antineoplastic agent; adult; aged; area under the curve; chemotherapy-induced febrile neutropenia; comparative study; complication; drug therapy; etiology; febrile neutropenia; female; hematologic disease; hospitalization; human; male; middle aged; neoplasm; receiver operating characteristic; retrospective study; risk assessment
Indonesian Society of Internal Medicine
01259326
39463107
Article
Q3
256
17265